Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Incorporate Good...

    Incorporate Good Distribution Practices guidelines as separate Schedule in Drugs and Cosmetics Rules, 1945: DTAB recommendation

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-09-09T15:56:42+05:30  |  Updated On 16 Aug 2021 11:46 AM GMT

    New Delhi: In a move to provide quality drugs to patients, the Drugs Technical Advisory Board (DTAB) has recently recommended to include provisions on Good Distribution Practices (GDP) of Pharmaceutical Products in the Drugs and Cosmetics Rules, 1945 to incorporate GDP guidelines as a separate Schedule in the said rule.


    The DTAB was apprised that the objective of the quality control over drugs is to ensure that the patients get quality drugs. For this purpose, it is necessary to ensure the quality and identity of pharmaceutical products during all aspects of the distribution process which includes procurement, purchasing, storage, distribution, transportation, and associated documentation/ record-keeping practices. Each activity in the distribution system is required to be carried out in accordance with the principles of Good Distribution Practices (GDP).


    The involvement of unauthorized entities in the distribution and sale of pharmaceutical products is a matter of concern as it leads to an introduction of spurious drugs in the supply chain. It is the responsibility of all parties involved in the distribution of pharmaceutical products to ensure that the quality of pharmaceutical products and the integrity of the distribution chain are maintained throughout the distribution process.


    The said matter was deliberated earlier in the Drugs Consultative Committee meeting wherein the report of the sub-committee constituted for the preparation of Guidelines on GDP of Pharmaceutical Products was considered. The matter was also deliberated in the meeting of DCC and the DCC suggested taking necessary provisions to impart legal sanctity to the suggested guidelines as a Schedule to the Drugs and Cosmetics Rules, 1945 to penalize the offenders.


    Subsequently, a notice was issued to all State/UT Drugs Controllers and stakeholders inviting comments/ suggestions on the draft guidelines. Comments/ suggestions have been received and are compiled.


    DTAB in its meeting deliberated on the issue and agreed to incorporate GDP guidelines as a separate Schedule in the Drugs and Cosmetics Rules, 1945.


    Further, this issue of incorporation of GDP guidelines as a separate Schedule was deliberated in the DCC meeting and it is recommended to make necessary provisions for Good Distribution Practice under the Drugs and Cosmetics Rules, 1945.

    https://pubads.g.doubleclick.net/gampad/ads?iu=/21687779244/clinicalkey_video_ad&description_url=[placeholder]&tfcd=0&npa=0&sz=640x480&gdfp_req=1&output=vast&unviewed_position_start=1&env=vp&impl=s&correlator=

    DTAB deliberated the matter and recommended to amend the Drugs & Cosmetics Rules, 1945 for provisions for Good Distribution Practices (GDP) of pharmaceutical products.


    Also Read: Grant of Manufacturing License for Drugs: DTAB recommends amendment of Drugs and Cosmetics Rules, 1945

    CDSCO CDSCO committee CDSCO meeting DCC meeting Drugs and Cosmetics Act Drugs and Cosmetics Rules Drugs Consultative Committee Drugs Technical Advisory Board DTAB DTAB meeting GDP Goods Distribution Practices pharma news pharma news india pharma products quality drugs State Drug Controller UT 

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier

      This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:

      Search only trustworthy HONcode health websites:

      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

      © 2020 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      X